KCT0003196尚未招募未知
Tailored hydration for the prevention of post-ERCP(endoscopic retrograde cholangiopancreatography) pancreatitis
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 80(Year)(—)
- 性别
- All
入选标准
- •All patients older than 20 years undergoing ERCP for the 1st time
排除标准
- •Age below 20 or above 80 years
- •Underlying severe psychiatric illness
- •Cardiac insufficiency (>New York Heart Association Class II heart failure)
- •Renal insufficiency (eGFR <30mililiter/min/1.73m2)
- •Respiratory insufficiency (defined as oxygen saturation < 90%)
- •Poorly controlled blood sugar
- •Ongoing hypotension including those with sepsis
- •Ongoing acute pancreatitis
- •Underlying disease of chronic pancreatitis
- •Clinical signs of hypervolemia
- •Hyponatremia (Na+ levels < 130 miliequivalent (mEq)/L))
- •Hypernatremia (Na+ levels > 150mEq/L)
- •Hyperkalemia (5.1 mEq/dL)
- •Metabolic alkalosis
- •Past history of endoscopic sphincterectomy or endoscopic papillary balloon dilatation
研究者
相似试验
招募中
不适用
Fluid hydration to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: the FLUYT-prevent trial. a multicenter randomized controlled superiority trial.;Pancreatic duct stent placement to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in patients with unintended PD-wire cannulation: a multicenter prospective cohortpost-ERCP pancreatitisinflammation of the pancreas following ERCP10017969NL-OMON54543Sint Antonius Ziekenhuis1,108
进行中(未招募)
1 期
intravenous fluid administration to prevent pancreatic inflammation following endoscopic bile duct examination.Patients with choledocholithiasisEUCTR2015-000829-37-NLRadboud University Medical Center826
已完成
不适用
Tailored Hydration for the Prevention of Post-ERCP PancreatitisCholangiopancreatography, Endoscopic RetrogradePancreatitisNCT03561441Chonnam National University Hospital350
已完成
不适用
FLUYT-prevent trialISRCTN13659155Radboud University Medical Center826
已完成
不适用
Protection against acute renal failure following cardiac surgeryISRCTN98672577Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)1,100
